VENTAVIS

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, Spain, Turkey, UK.

Active ingredients

The drug VENTAVIS contains one active pharmaceutical ingredient (API):

1	Iloprost trometamol UNII JED5K35YGL - ILOPROST
	Iloprost is a synthetic prostacyclin analogue. After inhalation of iloprost direct vasodilatation of the pulmonary arterial bed occur with consecutive significant improvement of pulmonary artery pressure, pulmonary vascular resistance and cardiac output as well as mixed venous oxygen saturation.
	Read more about Iloprost

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VENTAVIS Nebuliser solution	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AC11	Iloprost	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5751Q, 6456T
BR	Câmara de Regulação do Mercado de Medicamentos	538902401131318
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.196-08-06
EE	Ravimiamet	1205390, 1205402, 1205413, 1291890, 1291902, 1365027, 1662948, 1662959, 1701717, 1701728
ES	Centro de información online de medicamentos de la AEMPS	03255004
FI	Lääkealan turvallisuus- ja kehittämiskeskus	054388
FR	Base de données publique des médicaments	66048871
GB	Medicines & Healthcare Products Regulatory Agency	113837, 357911, 365516, 372488, 379149
IE	Health Products Regulatory Authority	88520
IL	מִשְׂרַד הַבְּרִיאוּת	4973
IT	Agenzia del Farmaco	036019014, 036019026, 036019038, 036019040, 036019053, 036019091, 036019103, 036019115, 036019127, 036019139, 036019141
JP	医薬品医療機器総合機構	2190701G1025
LT	Valstybinė vaistų kontrolės tarnyba	1031155, 1031156, 1031157, 1031158, 1031159, 1034201, 1038374, 1038375, 1076821, 1076822, 1076823, 1076824, 1081753, 1081754
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	335M2006
NL	Z-Index G-Standaard, PRK	127124, 132713
NZ	Medicines and Medical Devices Safety Authority	12579
PL	Rejestru Produktów Leczniczych	100126548, 100145824
SG	Health Sciences Authority	13140P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699546754892, 8699546754908, 8699546754915, 8699546754922
US	FDA, National Drug Code	66215-302, 66215-303